Robert T Foster's Net Worth
-$57.8 Thousand
Who is Robert T Foster?
Robert T Foster does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ContraVir Pharmaceuticals, Inc., and Aurinia Pharmaceuticals Inc..
SEC CIK
Robert T Foster's CIK is 0001677370
Past Insider Trading and Trends
2023 was Robert T Foster's most active year for acquiring shares with 4 total transactions. Robert T Foster's most active month to acquire stocks was the month of August. 2021 saw Robert T Foster paying a total of $40,000.00 for 1,920,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ContraVir Pharmaceuticals, Inc. (HEPA) Snapshot price: $0.7771
CEO and DirectorRobert T Foster owns 50,470 units of Common Stock which is worth $39,220.24. In the year 2016 Robert T Foster acquired a total of 192,936 shares in ContraVir Pharmaceuticals, Inc. at a cost of $97,017.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.27% | 1.6K |
$5.60 | $8,960.00 | 50.47K |
Sep 18
| |||
Form 4
| +3.38% | 1.6K |
$5.40 | $8,640.00 | 48.87K |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +79.18% | 20K |
$2.00 | $40,000.00 | 45.26K |
Feb 18
| |||
Form 4
| +9,652.51% | 25K |
$1.58 | $39,417.50 | 25.26K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
| +228.33% | 100.65K |
—
|
—
| 144.74K |
Jan 3
| |||
Form 4
|
∞
| 44.08K |
—
|
—
| 44.08K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aurinia Pharmaceuticals Inc. (AUPH) Snapshot price: $7.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||